Jacobs Levy Equity Management, Inc Moderna, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $23.9 Billion
- Q3 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 1,449,931 shares of MRNA stock, worth $35.9 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
1,449,931
Previous 1,345,950
7.73%
Holding current value
$35.9 Million
Previous $37.1 Million
0.85%
% of portfolio
0.16%
Previous 0.15%
Shares
3 transactions
Others Institutions Holding MRNA
# of Institutions
846Shares Held
258MCall Options Held
40.2MPut Options Held
44M-
Vanguard Group Inc Valley Forge, PA41.2MShares$1.02 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$633 Million0.07% of portfolio
-
Baillie Gifford & CO21.8MShares$541 Million0.44% of portfolio
-
State Street Corp Boston, MA17.1MShares$424 Million0.02% of portfolio
-
Morgan Stanley New York, NY9.96MShares$247 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $9.69B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...